IE 11 is not supported. For an optimal experience visit our site on another browser.

AstraZeneca vaccine may take longer to get FDA approval


AstraZeneca’s CEO is telling Bloomberg News that the company might conduct another international study of its coronavirus vaccine candidate that might take longer to get FDA approval. NBC’s Gabe Gutierrez reports for TODAY.